Comparing the impact of OFA (opioid free anesthesia) and steroids on the quality of recovery after Hip Arthroplasty by Direct Anterior Approach Using Minimally Invasive Surgery: a case-control study.

Autor: KORTHOUDT, C., VAN LOMMEL, J., VANDEKERCKHOVE, M., DE RYCKE, J., MULIER, J.

Publikováno v: Acta Anaesthesiologica Belgica; 2021 Supplement, Vol. 72, p71-76, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

Autor: Eriksson, Bi, Borris, Lc, Friedman, Rj, Haas, S, Huisman, Mv, Kakkar, Ak, Bandel, Tj, Beckmann, H, Muehlhofer, E, Misselwitz, F, Geerts, W, COLLABORATORS: Eriksson BI, RECORD1 Study G. r. o. u. p., Levine, M, Eriksson, H, Sandrgen, G, Wallin, J, Bode, C, Bassand, Jp, Lüscher, T, Angeras, U, Falk, A, Prins, M, Leizorovicz, A, Bounameaux, H, Larrey, D, Migge, A, Caviglia, H, Ceresetto, J, Cicchetti, A, D'Onofrio, A, Diaz, A, Mendler, H, Saa, J, Blombery, P, Chong, B, Gallus, A, Leahy, M, Salem, H, Bauer, N, Boehl, N, Freund, N, Hochreiter, J, Jakubek, M, Labek, G, Windhager, R, Zenz, P, Borms, T, Brabants, C, Colinet, J, de Rycke, J, Driesen, R, Gunst, P, Mortele, H, van Loon, L, Vandermeersch, E, Vanlommel, D, Queiroz, Rd, Fridman, M, Penedo, Jm, Schwartsmann, C, Abuzgaya, F, Belzile, E, Dobson, C, Fisher, W, Grosso, P, Mant, M, Pototschnik, R, Solymoss, S, Zalzal, P, Bittelman, S, Cordova, M, Reyes, A, Rocha, C, Toledo, D, Altschul, J, Fousek, J, Koudela, K, Kriz, Z, Lutonsky, M, Pach, M, Sedivy, P, Stehlik, J, Svagr, M, Svec, M, Borgwardt, Oa, Joergensen, P, Lassen, Mr, Lausten, G, Mikkelsen, S, Jokipii, P, Pesola, M, Waris, P, Debue, Jm, Forestier, C, Hennion, G, Lazard, T, Macaire, P, Maire, Jy, Marouan, A, Maschino, X, Matuszczak, Y, Moulinie, Jp, Osman, M, Peron, A, Pinson, Jj, Birkner, W, Buechler, M, Eulert, J, Fritsche, Hm, Guen, Kp, Halder, A, Horacek, T, Kiekenbeck, A, Kleinfeld, F, Krauspe, R, Kurth, A, Labs, K, Mittelme, W, Mouret, P, Muehlbauer, B, Quante, M, Schmelz, H, Wirth, T, Babis, G, Beldekos, A, Soukakos, P, Bucsi, L, Lenart, E, Mike, G, Sarvary, A, Shafiei, F, Szenbeni, A, Szendroi, M, Toth, J, Toth, K, Benkovich, V, Brenner, B, Dekel, S, Halperin, N, Hendel, D, Martinovich, U, Nyska, M, Salai, M, Borghi, B, Bosco, M, Castelli, C, Cherubino, P, Franchin, FRANCESCO MARIA, Fraschini, G, Greco, F, Grossi, P, Gusso, M, Landolfi, R, Leali, T, Lodigiani, C, Marinoni, E, Martorana, U, Massari, L, Melis, G, Miletto, A, Parise, P, Rinaldi, G, Riva, R, Silingardi, M, Porvaneckas, N, Smailys, A, Dijk, Cn, Nolte, Pa, Schuller, Hm, Slappendel, R, van der List JJ, Verheyen, Cc, Vis, Hm, Aarseth, O, Al Dekany, K, Borgen, P, Roenning, Re, Talsnes, O, Bednarek, A, Blacha, J, Deszczyski, J, Dutka, J, Gazdzik, T, Golec, E, Gorecki, A, Gusta, A, Krasicki, M, Kruczyski, J, Kusz, D, Kwiatkowsk, K, Mazurkiewi, S, Niedwiedzki, T, Pozowski, A, Skowronski, J, Swaton, R, Synder, M, Tkaczyk, T, Knapec, L, Lisy, M, Stasko, I, Engelbrecht, J, Myburgh, H, van Zyl, L, Canosa Sevillano, R, Delgado, A, Diaz Almodovar JL, Giros Torres, J, Granero, X, Gomar, F, Lecumberri Villamedi, R, Navarro Quiles, A, Otero Fernandez, R, Paz Jimenez, J, Peidro Garces, L, Pino Minguez, J, Puig Verdier, L, Ruiz Sanchez, A, Salvador, A, Valdes Casas JC, Laestander, H, Liliequist, J, Lind, S, Paulsson, B, Wykman, A, Altintas, F, Esemelli, T, Karatosun, V, Togrul, E, Tozun, R, Allmacher, D, Buettner, C, Colwell C., Jr, Friedman, R, Gimbel, J, Jove, M, King, R, Martin, K, Murray, R, Peters P., Jr, Sledge, S, Swappach, J, Taunton O., Jr, Ward, J.

BACKGROUND: This phase 3 trial compared the efficacy and safety of rivaroxaban, an oral direct inhibitor of factor Xa, with those of enoxaparin for extended thromboprophylaxis in patients undergoing total hip arthroplasty. METHODS: In this randomized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a791515fb8f3716cb711bd5bfeeeba
http://hdl.handle.net/11585/118703

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interaction of Escherichia coli producing cytotoxic necrotizing factor with HeLa epithelial cells

Autor: De Rycke J, Jean-Philippe Nougayrede, Oswald E, Mazars P

Publikováno v: Europe PubMed Central

Cytotoxic necrotizing factors (CNF) constitute a group a cell-associated proteic toxins of 110-115 kDa produced by some clinical isolates of Escherichia coli from man and animals. Purified CNFs are known to exacerbate actin polymerization in exposed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::24c8598759a75d8a1517772d34e72bf9
https://pubmed.ncbi.nlm.nih.gov/9192042